Developer docs
API playgroundTry for free, no card

Search company profiles

Alpen Group

Full company profile

uuid000da5e

Namestring
Alpen Group
Legal namestring
Alpen Group SA
Websiteurl
alpengroup.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Alpen Group SA is a Swiss private cannabis manufacturer and distributor operating across two sites in Ticino — an EU-GMP contract manufacturing facility in Bioggio and a cultivation campus and headquarters in Quartino. The company produces medical cannabis products to European Union Good Manufacturing Practice standards and runs GDP-compliant (Good Distribution Practice) trading and processing operations for international licensed operators. As an Authorized Producer within Switzerland's Federal Office of Public Health (FOPH) cannabis pilot programs, Alpen Group supplies finished products that are dispensed through a growing network of pharmacies and retail locations participating in regulated pilot trials.

The company monetizes through three interlocking revenue streams: EU-GMP contract manufacturing for regulated producers, finished-product supply into the Swiss Pilot Programs, and global GDP-compliant trading and processing for medical cannabis products. Its product portfolio includes EUGMP-manufactured cannabis, pilot-program SKUs, and — under an exclusive Swiss manufacturing partnership with Wana Brands (ranked the No. 1 cannabis edible brand globally) — premium cannabis edibles adapted to local regulatory requirements. Marketing and customer acquisition run through direct B2B engagement, including a website contact form and email inquiries (info@alpengroup.com); pricing is not publicly disclosed.

Alpen Group is led by a multidisciplinary team with backgrounds in pharmaceuticals, life sciences, regulated cannabis, manufacturing, and private equity. The company holds EU-GMP and GDP certifications, leverages "Swiss-made" brand equity for premium positioning, and positions itself as a platform designed for the next phase of European regulated cannabis manufacturing as the continent moves toward broader legalization frameworks.

Short descriptiontext

Alpen Group SA is a Swiss EU-GMP-certified manufacturer and distributor of medical cannabis products, operating an authorized-producer platform that supplies finished products into Switzerland's FOPH cannabis pilot programs via pharmacies and retail dispensaries, with additional GDP-compliant international trading and an exclusive Swiss edible partnership with Wana Brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLugano, Switzerland
HQ citystring
Lugano
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical cannabis manufacturing, EU-GMP contract manufacturing, medical cannabis distribution, cannabis pilot programs, GDP-compliant trading
Industry1 code
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Cannabis Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1EU-GMP Contract Manufacturing
TypeTransaction Fee
Description

Manufacturing medical cannabis products to EU-GMP standards for authorized producers and licensed operators in regulated markets.

alpengroup.com
2Swiss Pilot Program Supply
TypeTransaction Fee
Description

Supplying finished cannabis products to support research in the FOPH (Federal Office of Public Health) Pilot Programs as an authorized producer.

alpengroup.com
3GDP Trading & Processing
TypeTransaction Fee
Description

Providing global GDP-compliant trading and processing services for medical cannabis products across international markets.

alpengroup.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Wana Brands (partnership)
Description

Alpen Group is the exclusive Swiss partner of Wana Brands, responsible for introducing and manufacturing Wana products within Switzerland's cannabis pilot programs. Wana Brands is ranked as the No. 1 edible brand globally.

alpengroup.com
Core offering1 text field

Alpen Group manufactures medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards and supplies finished products as an Authorized Producer to Switzerland's FOPH Cannabis Pilot Programs. The company also provides GDP-compliant trading and processing services for medical cannabis across international markets, and serves as the exclusive Swiss manufacturing partner of Wana Brands for cannabis edible products.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Alpen Group operates as a regulated cannabis manufacturer offering a portfolio of services and products. The core offerings include EUGMP Cannabis Contract Manufacturing services, GDP Trading & Processing for compliant international distribution, and finished products for Switzerland's FOPH Pilot Programs. Under the Wana Brands sub-brand, Alpen Group manufactures world-leading cannabis edibles (ranked No. 1 edible brand globally) as the exclusive Swiss partner, adapting proven formulations to Swiss regulatory requirements. The company positions these offerings as integrated capabilities spanning product development, manufacturing, and controlled supply within tightly governed regulatory frameworks.

Product and service4 records
1EUGMP Cannabis Contract Manufacturing
CategoryContract Manufacturing Services
Description

Contract manufacturing service producing medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards for licensed cannabis operators and authorized producers in regulated European markets.

2GDP Trading and Processing
CategoryTrading and Distribution Services
Description

Global GDP-compliant (Good Distribution Practice) trading and processing services for medical cannabis products, enabling compliant international supply chain operations across regulated markets.

3Swiss Pilot Program Products
CategoryFinished Pharmaceutical Cannabis Products
Description

Finished cannabis products supplied to support research in the FOPH (Federal Office of Public Health) Pilot Programs, dispensed through pharmacies and retail locations participating in Switzerland's authorized cannabis pilot trials.

4Wana Brands Edibles
CategoryCannabis Edible Products
Description

Premium cannabis edible products manufactured under the exclusive Swiss partnership with Wana Brands — the world's leading and No. 1 ranked cannabis edible brand globally — adapted to Swiss regulatory requirements for distribution within Swiss cannabis pilot programs.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing Partner
Description

Alpen Group is the exclusive Swiss partner of Wana Brands, responsible for introducing and manufacturing Wana cannabis edible products within Switzerland's cannabis pilot programs. This partnership brings globally proven formulations and quality standards to the Swiss market, adapted carefully to local regulatory requirements. By partnering with Wana Brands, Alpen Group is setting a new benchmark for cannabis edibles in Switzerland.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

European medical cannabis distributor and manufacturer focused on pharmacy supply chains. Comparable to Alpen Group's pharmacy-led distribution model and EU-GMP supply approach.

TypeEmerging player
Description

Canadian cannabis producer with EU-GMP certification pursuing European medical cannabis distribution. Comparable as a focused manufacturer expanding into regulated European channels.

TypeDirect peer
Description

German medical and consumer cannabis company with EU-GMP production capabilities and pharmaceutical partnerships. Directly comparable in regulated European cannabis manufacturing and B2B pharma positioning.

TypeBroad incumbent
Description

Global medical cannabis producer with EU-GMP facilities supplying European markets. Comparable as a larger incumbent competing in EU-GMP contract manufacturing and distribution.

TypeBroad incumbent
Description

Large global cannabis operator with European medical cannabis operations including EU-GMP production. Comparable as a multinational incumbent targeting regulated European cannabis channels.

TypeDirect peer
Description

European medical cannabis distribution platform connecting manufacturers with pharmacies. Comparable to Alpen Group's GDP-compliant trading and pharmacy-channel distribution focus.

TypeBroad incumbent
Description

Pharmaceutical company with the only EU-approved cannabis-based medicines (Sativex, Epidiolex). Comparable as a pharmaceutical-grade cannabis player operating in tightly regulated frameworks.

TypeDirect peer
Description

Vertically integrated German medical cannabis company with EU-GMP manufacturing and cultivation. Direct comparable to Alpen Group's EU-GMP manufacturing and regulated B2B channel focus.

TypeDirect peer
Description

German-based EU-GMP certified medical cannabis producer and distributor supplying pharmacies across Europe. Direct comparable to Alpen Group's EU-GMP contract manufacturing and GDP-compliant distribution model.

10Tilray Brands
TypeBroad incumbent
Description

Global cannabis incumbent with EU-GMP manufacturing, broad medical cannabis portfolio, and European distribution. Comparable as a scaled EU-GMP operator competing for the same European medical cannabis contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alpen Group

Pharmaceutical Cannabis Manufacturingalpengroup.com

Alpen Group SA is a Swiss EU-GMP-certified manufacturer and distributor of medical cannabis products, operating an authorized-producer platform that supplies finished products into Switzerland's FOPH cannabis pilot programs via pharmacies and retail dispensaries, with additional GDP-compliant international trading and an exclusive Swiss edible partnership with Wana Brands.

What Alpen Group does

Alpen Group SA is a Swiss private cannabis manufacturer and distributor operating across two sites in Ticino — an EU-GMP contract manufacturing facility in Bioggio and a cultivation campus and headquarters in Quartino. The company produces medical cannabis products to European Union Good Manufacturing Practice standards and runs GDP-compliant (Good Distribution Practice) trading and processing operations for international licensed operators. As an Authorized Producer within Switzerland's Federal Office of Public Health (FOPH) cannabis pilot programs, Alpen Group supplies finished products that are dispensed through a growing network of pharmacies and retail locations participating in regulated pilot trials.

The company monetizes through three interlocking revenue streams: EU-GMP contract manufacturing for regulated producers, finished-product supply into the Swiss Pilot Programs, and global GDP-compliant trading and processing for medical cannabis products. Its product portfolio includes EUGMP-manufactured cannabis, pilot-program SKUs, and — under an exclusive Swiss manufacturing partnership with Wana Brands (ranked the No. 1 cannabis edible brand globally) — premium cannabis edibles adapted to local regulatory requirements. Marketing and customer acquisition run through direct B2B engagement, including a website contact form and email inquiries (info@alpengroup.com); pricing is not publicly disclosed.

Alpen Group is led by a multidisciplinary team with backgrounds in pharmaceuticals, life sciences, regulated cannabis, manufacturing, and private equity. The company holds EU-GMP and GDP certifications, leverages "Swiss-made" brand equity for premium positioning, and positions itself as a platform designed for the next phase of European regulated cannabis manufacturing as the continent moves toward broader legalization frameworks.

Alpen Group firmographics

Firmographics
Name
Alpen Group
Legal name
Alpen Group SA
Website
https://alpengroup.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Alpen Group SA is a Swiss EU-GMP-certified manufacturer and distributor of medical cannabis products, operating an authorized-producer platform that supplies finished products into Switzerland's FOPH cannabis pilot programs via pharmacies and retail dispensaries, with additional GDP-compliant international trading and an exclusive Swiss edible partnership with Wana Brands.
Ownership category
akta.pro rank

Alpen Group industry classification

Industry
Product category
Pharmaceutical Cannabis Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Pharmaceutical cannabis manufacturing
  • EU-GMP contract manufacturing
  • Medical cannabis distribution
  • Cannabis pilot programs
  • GDP-compliant trading

Where Alpen Group is headquartered

Location

Headquarters

HQ city
Lugano
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Alpen Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. EU-GMP Contract Manufacturing: Manufacturing medical cannabis products to EU-GMP standards for authorized producers and licensed operators in regulated markets.
  2. Swiss Pilot Program Supply: Supplying finished cannabis products to support research in the FOPH (Federal Office of Public Health) Pilot Programs as an authorized producer.
  3. GDP Trading & Processing: Providing global GDP-compliant trading and processing services for medical cannabis products across international markets.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Alpen Group product offering

Product offering

Core offering

Alpen Group manufactures medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards and supplies finished products as an Authorized Producer to Switzerland's FOPH Cannabis Pilot Programs. The company also provides GDP-compliant trading and processing services for medical cannabis across international markets, and serves as the exclusive Swiss manufacturing partner of Wana Brands for cannabis edible products.

Product overview

Alpen Group operates as a regulated cannabis manufacturer offering a portfolio of services and products. The core offerings include EUGMP Cannabis Contract Manufacturing services, GDP Trading & Processing for compliant international distribution, and finished products for Switzerland's FOPH Pilot Programs. Under the Wana Brands sub-brand, Alpen Group manufactures world-leading cannabis edibles (ranked No. 1 edible brand globally) as the exclusive Swiss partner, adapting proven formulations to Swiss regulatory requirements. The company positions these offerings as integrated capabilities spanning product development, manufacturing, and controlled supply within tightly governed regulatory frameworks.

Differentiator

Problem solved

Functional benefit

Brands

  • Wana Brands (partnership): Alpen Group is the exclusive Swiss partner of Wana Brands, responsible for introducing and manufacturing Wana products within Switzerland's cannabis pilot programs. Wana Brands is ranked as the No. 1 edible brand globally.

Products and services

  • EUGMP Cannabis Contract Manufacturing Contract manufacturing service producing medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards for licensed cannabis operators and authorized producers in regulated European markets.
  • GDP Trading and Processing Global GDP-compliant (Good Distribution Practice) trading and processing services for medical cannabis products, enabling compliant international supply chain operations across regulated markets.
  • Swiss Pilot Program Products Finished cannabis products supplied to support research in the FOPH (Federal Office of Public Health) Pilot Programs, dispensed through pharmacies and retail locations participating in Switzerland's authorized cannabis pilot trials.
  • Wana Brands Edibles Premium cannabis edible products manufactured under the exclusive Swiss partnership with Wana Brands — the world's leading and No. 1 ranked cannabis edible brand globally — adapted to Swiss regulatory requirements for distribution within Swiss cannabis pilot programs.

Companies that use Alpen Group

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Alpen Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Alpen Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Wana BrandsflagshipOEM/ Whitelabel/ Licensing PartnerAlpen Group is the exclusive Swiss partner of Wana Brands, responsible for introducing and manufacturing Wana cannabis edible products within Switzerland's cannabis pilot programs. This partnership brings globally proven formulations and quality standards to the Swiss market, adapted carefully to local regulatory requirements. By partnering with Wana Brands, Alpen Group is setting a new benchmark for cannabis edibles in Switzerland.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Alpen Group competitors and assessment

Company assessment

Direct peers

  • Nimbus Health: European medical cannabis distributor and manufacturer focused on pharmacy supply chains. Comparable to Alpen Group's pharmacy-led distribution model and EU-GMP supply approach.
  • Sanity Group: German medical and consumer cannabis company with EU-GMP production capabilities and pharmaceutical partnerships. Directly comparable in regulated European cannabis manufacturing and B2B pharma positioning.
  • Cansativa: European medical cannabis distribution platform connecting manufacturers with pharmacies. Comparable to Alpen Group's GDP-compliant trading and pharmacy-channel distribution focus.
  • Demecan: Vertically integrated German medical cannabis company with EU-GMP manufacturing and cultivation. Direct comparable to Alpen Group's EU-GMP manufacturing and regulated B2B channel focus.
  • Cannamedical Pharma: German-based EU-GMP certified medical cannabis producer and distributor supplying pharmacies across Europe. Direct comparable to Alpen Group's EU-GMP contract manufacturing and GDP-compliant distribution model.

Emerging players

  • OrganiGram Holdings: Canadian cannabis producer with EU-GMP certification pursuing European medical cannabis distribution. Comparable as a focused manufacturer expanding into regulated European channels.

Broad incumbents

  • Aurora Cannabis: Global medical cannabis producer with EU-GMP facilities supplying European markets. Comparable as a larger incumbent competing in EU-GMP contract manufacturing and distribution.
  • Canopy Growth: Large global cannabis operator with European medical cannabis operations including EU-GMP production. Comparable as a multinational incumbent targeting regulated European cannabis channels.
  • Jazz Pharmaceuticals (GW Pharmaceuticals): Pharmaceutical company with the only EU-approved cannabis-based medicines (Sativex, Epidiolex). Comparable as a pharmaceutical-grade cannabis player operating in tightly regulated frameworks.
  • Tilray Brands: Global cannabis incumbent with EU-GMP manufacturing, broad medical cannabis portfolio, and European distribution. Comparable as a scaled EU-GMP operator competing for the same European medical cannabis contracts.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Alpen Group social profiles

Digital presence

Alpen Group compliance and trust

Trust signal

Compliance2 records

Alpen Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alpen Group leadership team

Management profile

Number of profiles

Alpen Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alpen Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alpen Group

What does Alpen Group do?

Alpen Group manufactures medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards and supplies finished products as an Authorized Producer to Switzerland's FOPH Cannabis Pilot Programs. The company also provides GDP-compliant trading and processing services for medical cannabis across international markets, and serves as the exclusive Swiss manufacturing partner of Wana Brands for cannabis edible products.

Is Alpen Group a public or private company?

Alpen Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Alpen Group founded?

Alpen Group was founded in 2022. It employs 1 to 10 people.

Where is Alpen Group based?

Alpen Group is headquartered in Lugano, Switzerland, in the Europe region.

How does Alpen Group make money?

Three revenue lines are on record. EU-GMP Contract Manufacturing is the primary driver. The others are swiss Pilot Program Supply and GDP Trading & Processing.

Who are Alpen Group's main competitors?

Direct peers on record are Nimbus Health, Sanity Group, Cansativa, Demecan and Cannamedical Pharma. OrganiGram Holdings is listed as an emerging player. Broad incumbents are Aurora Cannabis, Canopy Growth, Jazz Pharmaceuticals (GW Pharmaceuticals) and Tilray Brands.

Does Alpen Group have an API?

No public API is recorded for Alpen Group.

What industry is Alpen Group in?

Alpen Group's product category is Pharmaceutical Cannabis Manufacturing. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325412 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsweedSt. Gallen, Switzerland, Launches Its 7th Legal Cannabis Pilot ProjectThe canton of St. Gallen in Switzerland has launched one of the country's largest cannabis pilot projects, allowing 3,300 to 5,000 adult participants from 42 municipalities to legally access regulated cannabis products over a period of up to five years. The study, led by the Swiss Cannabis Research Association in collaboration with the University of Zurich and KOF Institute of ETH Zurich and approved by the Federal Office of Public Health, uses a randomized controlled trial methodology to examine the social, economic, and health impacts of regulated cannabis access. Participants can purchase laboratory-tested products including cannabis flowers, hashish, vape pens, THC oils, and edibles supplied by Alpina Pharma, SwissExtract, Charlies Lab, Alpen Group, and Wana Brands from pharmacies, dedicated retail locations, or through home delivery.BizWestWana Brands eyes European market with Alpen Group deal – BizWestWana Brands, a Boulder-based cannabis edibles maker, partnered with Swiss company Alpen Group to enter the European market, aiming to launch its gummies in Switzerland by 2025. The deal would make Wana the first American company operating in the European edibles space, with production in a Swiss facility.ForbesOne Of The Largest U.S. Edibles Brands Is Coming To EuropeWana Brands, a U.S. cannabis edibles company, will be the first American brand to introduce cannabis-infused edibles to Europe, starting with Switzerland via a partnership with Alpen Group. The launch is anticipated by 2025, coinciding with Switzerland's approval of pilot trials for non-medicinal cannabis dispensation. The move signals potential for broader European expansion.